Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Chenming Zhang

Has grant

Professor

Virginia Tech

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Open

Novel nanosensors for the rapid and sensitive detection of animal diseases

Open Date: 2023-09-01

Close Date: 2027-08-31

Grant: Open

Nanoparticle-based swine vaccine

Open Date: 2022-01-01

Close Date: 2026-12-31

Grant: Close

Novel nanovaccines against opioid use disorders

Open Date: 2019-07-15

Close Date: 2024-06-30

Grant: Close

Detection and Control of Porcine Reproductive and Respiratory Syndrome Virus and Emerging Viral Diseases of Swine

Open Date: 2016-07-01

Close Date: 2019-09-30

Grant: Close

Novel Nanovaccines Against Nicotine Addiction

Open Date: 2014-07-01

Close Date: 2018-05-31

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

Sydney Horizon Fellow, Senior Lecturer

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chenming Zhang

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (12)

A Fentanyl‐Responsive Microneedle Patch for Harm Reduction

From lab to market: Challenges in translating biosensor innovations to benefit agricultural animal health

IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine

Engineering next-generation nanovaccines for maternal immunization and piglet protection against porcine epidemic diarrhea virus

Erratum to “Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders” (Journal of Controlled Release (2025) 388(P1), (S0168365925009071), (10.1016/j.jconrel.2025.114294))

Safety and Toxicological Evaluation of Subunit Keyhole Limpet Hemocyanin-Loaded Lipid–PLGA Hybrid Nanoparticles (sKLH-hNPs) as a Nanocarrier for an Opioid Use Disorder Vaccine

The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines

Precision Adjuvant Strategies in Vaccine Development for Substance Use Disorders: Variability and Mechanistic Insights

The pH-Dependent Specificity of Cathepsin S and Its Implications for Inflammatory Communications and Disease

Conjugation of Multiple Proteins Onto the Surface of PLGA/Lipid Hybrid Nanoparticles

Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders

Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists

Collaborators (6)

Xin M. Luo

Priscila Beatriz da Silva Serpa

Teresa Southard

Justin Lemkul

Marion Ehrich

Chun Xu

Make your next move.